Affordable Access

Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease.

Authors
  • Lepor, N E
  • Gross, S B
  • Daley, W L
  • Samuels, B A
  • Rizzo, M J
  • Luko, S P
  • Hickey, A
  • Buchbinder, N A
  • Naqvi, T Z
Type
Published Article
Journal
The American Journal of Cardiology
Publisher
Elsevier
Publication Date
Jul 01, 2000
Volume
86
Issue
1
Pages
107–110
Identifiers
PMID: 10867106
Source
Medline
License
Unknown
Report this publication

Statistics

Seen <100 times